Expertise in
4
conditions

Denis C. Roy

52/1a, Sambhunath Pandit Street, 
Kolkata, WB, IN 
Expertise in
4
conditions
52/1a, Sambhunath Pandit Street, 
Kolkata, WB, IN 

Overview

Denis Roy practices practicing medicine in Kolkata, India.

Roy is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Atrial Fibrillation, Heart Block, Heart Failure, Cardiac Ablation, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 426 peer reviewed articles and participating in 4 clinical trials.

Locations

52/1a, Sambhunath Pandit Street, Kolkata, WB 700020, India
Other Locations
585 Grove Street, Herndon, VA 20170

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Enrollment Status: Terminated
Publish Date: June 15, 2025
Intervention Type: Other, Drug
Study Drug: Rivaroxaban
Study Phase: Phase 3
Canadian EdoxAban (Lixiana®) Registry in Patients With ATrial Fibrillation and/or ATrial Flutter With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)
Canadian EdoxAban (Lixiana®) Registry in Patients With ATrial Fibrillation and/or ATrial Flutter With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
A Phase III, Multicenter, Randomized Controlled Study to Compare Safety and Efficacy of a Haploidentical HSCT and Adjunctive Treatment With ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells, Versus a Haploidentical HSCT With Post-transplant Cyclophosphamide in Patients With a Hematologic Malignancy
A Phase III, Multicenter, Randomized Controlled Study to Compare Safety and Efficacy of a Haploidentical HSCT and Adjunctive Treatment With ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells, Versus a Haploidentical HSCT With Post-transplant Cyclophosphamide in Patients With a Hematologic Malignancy
Enrollment Status: Terminated
Publish Date: May 24, 2022
Intervention Type: Drug, Biological, Procedure
Study Drugs: ATIR101 Ex Vivo-Depleted T Lymphocyte-Enriched Leukocyte, Cyclophosphamide
Study Phase: Phase 3
An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of a Two-dose Regimen of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells (Using Photodynamic Treatment), in Patients With a Hematologic Malignancy, Who Received a CD34-selected Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of a Two-dose Regimen of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells (Using Photodynamic Treatment), in Patients With a Hematologic Malignancy, Who Received a CD34-selected Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Procedure, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

426 Total Publications

Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy.
Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy.
Journal: Circulation
Published: February 23, 2026

Frequently Asked Questions about Denis C. Roy

Is Denis C. Roy a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Denis C. Roy is classified as an Distinguished expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Denis C. Roy participate in research or clinical trials?

Yes. Denis C. Roy has published 426 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Denis C. Roy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Roy's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile